Related Experiment Videos
A new behavioral test for antidepressant drugs
European Journal of Pharmacology
|September 24, 1982
Summary
A novel water wheel test offers a more objective and specific method for screening antidepressants in mice compared to the traditional forced swimming test. This behavioral despair test improves accuracy in identifying potential antidepressant drugs.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- The Porsolt forced swimming test (FST) is a widely used behavioral assay for screening antidepressant drugs in rodents.
- However, the FST has limitations, including subjective immobility assessment and a lack of specificity, leading to potential false positives.
Purpose of the Study:
- To develop and validate a new, more objective and specific behavioral test for screening antidepressant compounds.
- To address the limitations of the Porsolt forced swimming test in antidepressant drug discovery.
Main Methods:
- A novel 'behavioral despair' test was designed using a small water wheel apparatus in a water tank.
- Mice were placed on the water wheel, and their rotations were counted as a measure of their attempts to escape.
- The effects of various drug classes, including antidepressants, tranquillizers, anticholinergics, and antihistaminics, were evaluated using this new test.
Main Results:
- All tested antidepressant drugs significantly increased the number of water wheel rotations.
- Tranquillizers, anticholinergics, and antihistaminics did not effectively alter the number of rotations, indicating higher specificity.
- The water wheel test provided objective, quantifiable data on mouse behavior.
Conclusions:
- The water wheel test demonstrates superior objectivity and specificity compared to the Porsolt forced swimming test for antidepressant screening.
- This new assay offers a promising alternative for more accurate identification of potential antidepressant medications.
- The findings suggest improved efficiency and reliability in preclinical antidepressant drug development.